Pasithea Therapeutics Corp. Warrant (KTTAW) stock forecast
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.
This KTTAW forecast page states what the cached financials imply — not a price target and not a guarantee. Pasithea Therapeutics Corp. Warrant outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for KTTAW yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for KTTAW, so this page does not invent a growth rate.
KTTAW currently screens at market cap $0. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next KTTAW 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the KTTAW stock page.
Not investment advice.